| Christopher M Boxell, MD | |
|
9001 S 101st E Ave, Suite 190, Tulsa, OK 74133 | |
| (918) 392-9670 | |
| (918) 392-9680 |
| Full Name | Christopher M Boxell |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 9001 S 101st E Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881645851 | NPI | - | NPPES |
| 100138620A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 18307 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher M Boxell, MD 9001 S 101st E Ave, Suite 190, Tulsa, OK 74133 Ph: (918) 392-9670 | Christopher M Boxell, MD 9001 S 101st E Ave, Suite 190, Tulsa, OK 74133 Ph: (918) 392-9670 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, today announced the Canadian approval of its Perceval sutureless aortic valve.
Celera Corporation and its collaborators at the University of California at San Francisco today announced the publication of a paper confirming the association of an increased risk of coronary heart disease (CHD) and two variants of the LPA gene. The two LPA single nucleotide polymorphisms (SNPs) are Ile4399Met, a polymorphism in the protease-like domain of LPA, and rs10455872, a SNP located in a non-coding region of the LPA gene.
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today reported financial results for the three months ended March 31, 2015.
› Verified 4 days ago
Dr. Tyler Sean Auschwitz, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 South Wheeling, Ste 200, St. Johns Neuroscience Institute, Tulsa, OK 74104 Phone: 918-748-7854 | |
Joel Nathan Abramovitz, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 S Wheeling Ave, Suite 200, Tulsa, OK 74104 Phone: 918-748-7584 Fax: 918-293-3116 | |
Allan Gregory Rosenfeld, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2000 S Wheeling Ave, Ste 200, Tulsa, OK 74104 Phone: 918-748-7854 Fax: 918-293-3116 | |
Dr. Brian James Hood, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-744-2345 | |
Daniel James Boedeker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6767 S Yale Ave, Suite A, Tulsa, OK 74136 Phone: 918-492-7587 | |
Ryan Alexander Zengou, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6475 S Yale Ave Ste 308, Tulsa, OK 74136 Phone: 918-499-4000 Fax: 918-499-4001 | |
Mohammad Yashar S Kalani, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 S Wheeling Ave Ste 200, Tulsa, OK 74104 Phone: 918-748-7854 Fax: 918-403-6335 |